Ruggenenti, Piero
Fervenza, Fernando C.
Remuzzi, Giuseppe
Article History
First Online: 3 July 2017
Competing interests
: F.C.F. has received unrestricted research grants from Genentech/Roche, the maker of rituximab. The other authors declare no competing interests.
Free to read: This content has been made available to all.